Aug 2 2019

HETLIOZ – (tasimelteon) is the only FDA-approved treatment for Non-24, vanda pharmaceuticals.#Vanda #pharmaceuticals

Welcome to HETLIOZ (tasimelteon)

The first and only FDA-approved treatment for Non-24-Hour Sleep-Wake Disorder (Non-24) .

HETLIOZSolutions is here to help.

HetliozSolutions is here to help. Sign up by calling 1-844-HETLIOZ . That’s 1-844-438-5469 , Monday through Friday, 9AM to 8PM, Eastern Standard Time. Learn more about HETLIOZSolutions .

About Non-24

Non-24-Hour Sleep-Wake Disorder is a serious, chronic disorder that disrupts a person’s circadian rhythms.


HETLIOZ is the first and only medication that’s been proven to treat people with Non-24 .


HETLIOZSolutions can help with questions about insurance coverage and prescription delivery, as well as provide educational resources.

Sign up for information about HETLIOZ

Keep up-to-date about Non-24 and HETLIOZ .

Here’s Important Safety Information for

HETLIOZ is indicated for the treatment of Non-24-Hour Sleep-Wake Disorder ( Non-24 ).

Important Safety Information

HETLIOZ (HeT-lee-ōz) is a prescription medication used to treat Non-24-Hour Sleep-Wake Disorder ( Non-24 ).

HETLIOZ may cause drowsiness. After taking HETLIOZ , limit your activity to preparing for bed. HETLIOZ can potentially impair your ability to perform activities that require complete mental alertness.

The most common side effects associated with HETLIOZ include headache, elevated liver enzymes (ALT), nightmares or abnormal dreams, and upper respiratory or urinary tract infection. These side effects may occur more frequently in patients 65 years of age or older.

Tell your healthcare provider about all of the medicines you’re taking. HETLIOZ should not be taken in combination with fluvoxamine or rifampin.

Tell your healthcare provider about all of your health conditions, including whether you are pregnant, are planning to become pregnant, or are breastfeeding. HETLIOZ has not been studied in pregnant women. HETLIOZ should be used during pregnancy only if the potential benefit justifies the potential risks.

HETLIOZ has not been studied in children and it is not recommended for use in patients with severe liver problems.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, call 1-800-FDA-1088 , or report by fax at 1-800-FDA-0178 .

For more information, ask your doctor or call 1-844-HETLIOZ (1-844-438-5469) .

This information does not take the place of talking with your doctor for medical advice about your condition or treatment.

Download an accessible PDF or listen to the full Prescribing Information. You can also hear the full Prescribing Information by calling 1-844-HETLIOZ (1-844-438-5469) .

Written by CIA

Notice: Undefined index: name in /Data/www/remmont.com/htdocs/wp-content/plugins/propellerads-official/includes/class-propeller-ads-anti-adblock.php on line 169
%d bloggers like this: